The big chains are angling for a larger slice of health care spending as new state laws allow pharmacists to treat minor ailments.

The recommendation is a huge win for the pharmaceutical company, likely paving the way for the company's first-of-its-kind gene therapy for treat Duchenne muscular dystrophy, a deadly disease.

The agency also simplified the COVID vaccination process, saying that anyone getting a Pfizer or Moderna dose — whether it's a booster or their first-ever vaccination — will get the newest formula, not the original shots.

In its third largest deal in the last decade, the pharmacy chain digs deeper into health care services, after buying Oak Street, which runs clinics that specialize in treating Medicare Advantage patients.